Check in with us as we feature the latest trends, research and news in medicine, health and science. A team of Star Tribune staffers will aggregate updates from news wires, websites, magazines and medical journals.

Cancer drug offers promise to MS patients

Posted by: Colleen Stoxen Updated: November 1, 2012 - 12:02 PM

A drug initially developed to treat some types of cancer now appears to help people suffering from multiple sclerosis (MS), a study said.

The drug, alemtuzumab, proved effective in patient trials at reducing relapses -- a key feature of MS which sees symptoms appear sporadically.

In one trial, patients who received the drug "were nearly half as likely to relapse within two years than those who received interferon", the most commonly-used MS drug, said a statement by the Lancet medical journal, which published the research. A second trial had similar results.

The outcome "offers the prospect of substantial improvement in quality of life and a better future for thousands of people with MS," said Alastair Compston from the University of Cambridge, principal investigator on both studies.

Many MS patients already use alemtuzumab, even though it has not been licensed for this purpose.

--AFP story and graphic

  • 0
  • Comments

Be the first to comment

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT